PLENARY KEYNOTE DISCUSSION
Perspectives on Evaluating Novel Diagnostics for Reimbursement
Andrew C. Fish,
Executive Director, AdvaMedDx
Elaine K. Jeter, M.D.,
J1 MolDx Medical Director, Palmetto GBA
Lee H. Newcomer, M.D.,
Senior Vice President, Oncology, United Healthcare
Dwight Denham, MBA,
Director, Clinical Research, Beckman Coulter, Inc.
Aaron D. Bossler, M.D., Ph.D.,
Clinical Assoc. Prof., Dir., Mol. Pathology Lab and
Mol. Genetic Pathology Fellowship Program, Univ.
of Iowa Hospitals and Clinics and Co-Chair, AMP
Economic Affairs Committee
- Meet all the major players in the evolving areas of diagnostics
- Get a comprehensive view of the changing landscape of diagnostics
- Network with 600+ global attendees
- Interactive Plenary Panel on Evaluating Novel Diagnostics for Reimbursement
- Connect with attendees using CHI’s Intro-Net
- Participate in the poster competition
- Choose from 14 pre-conference short courses
- View innovative products and novel technologies in the expansive exhibit hall
- And much more!